|

Effect of Adding Ultrasound Guided IPACK Block to Adductor Canal Block for Postoperative Pain in Knee Tumor Excision

RECRUITINGN/ASponsored by National Cancer Institute, Egypt
Actively Recruiting
PhaseN/A
SponsorNational Cancer Institute, Egypt
Started2025-08-15
Est. completion2026-05-30
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07382297

Summary

the aim of this study is to determine the analgesic effect of iPACK in combination to ACB after the excision of tumors around the Knee regarding the following: * Time to the 1st rescue analgesia. * Postoperative morphine consumption. * Postoperative visual analogue scale (VAS). This study will include patients, aged 18 to 65 years, belonging to the American Society of Anesthesiologists (ASA) physical status II to IV , undergoing excision of tumors around the knee under spinal anesthesia. Patients will be randomly allocated Group iPACK plus Adductor canal block (ACB) : patients will receive ACB plus iPACK block. • Control group : patients will not receive any block but will take morphine 3mg bolus at VAS more than 4 and regular NSAIDS and paracetamol iv.

Eligibility

Age: 18 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

* Stated willingness to comply with all study procedures and availability for the duration of the study
* American Society of Anesthesiologists (ASA) physical status II-IV.
* Patients undergoing excision of tumors around the knee under spinal anesthesia

Exclusion Criteria:

* Patient refusal.
* Neuromuscular disorders
* Allergy to local anesthetics
* Previous history of knee surgery
* Patients with a prior knee infection
* Contraindications to spinal anesthesia as coagulopathies and severe aortic stenosis.

Conditions2

CancerCancer Pain

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.